Fatty acid mobilization was effected in 24 anesthetized dogs by infusion of norepinephrine over a four-hour period. Infusions of propranolol and nicotinic acid at various doses, individually and in combination, were added and free fatty acid levels were serially determined. Synergistic action of the two agents was apparent in that minimally effective concentrations of the two agents when used in combination suppressed the release of free fatty acids to 29 percent of levels achieved with norepinephrine (1,186 ju,Eq/L) and 70 percent of levels in saline control animals (501 /j.Eq/L). Large individual doses were no more effective than low doses used in combination. The synergistic action of propranolol and nicotinic acid in the suppression of free fatty acid mobilization may be explained by the action of these two agents on the inhibition of the adenyl cyclase system of the adipose tissue cell. This synergistic action in reducing plasma free fatty acids and their effect on lipid synthesis would allow the use of smaller doses that could reduce the risk of side effects.
• This report describes a synergistic effect of low doses of propranolol and nicotinic acid on the suppression of the release of plasma free fatty acids. Each of these agents is known to cause plasma free fatty acids to fall when used in full concentrations (1) (2) (3) (4) . It has also been shown that under the influence of these agents plasma levels of cholesterol and triglyceride fall (3-7). Recent evidence indicates that the inhibitory mechanism of action of both propranolol and nicotinic acid on the release of plasma free fatty acids at the cellular level is mediated through inhibition of adenyl cyclase (8, 9) . barbital (30 mg/kg) with a single intravenous dose. Occasionally, 60-mg doses of pentobarbital were given subsequently to maintain anesthesia. A Harvard pump respirator, an arterial catheter, blood pressure recording equipment, and an intravenous catheter were connected to the animals. Continuous blood pressure and electrocardiographic recordings were made. Blood samples were taken at frequent intervals from the arterial catheter as indicated below. The first 5 ml of blood drawn from the arterial catheter was discarded. When several agents were infused, they were combined in the same bottle.
In each experiment, there was a 15-minute baseline period during which two blood samples were drawn. Then a norepinephrine infusion was started and continued in all the dogs for 4 hours. At various times during this infusion of norepinephrine, a single dose of propranolol or nicotinic acid was given intravenously and was followed by an intravenous infusion of these agents. Norepinephrine infusion was continued throughout die experiments in all dogs except the saline control animals. In some groups of dogs, both propranolol and nicotinic acid were included in the final infusion mixture.
In the high-dose experiments, the doses of propranolol and nicotinic acid which had a maximum effect in lowering plasma free fatty acid concentrations to prenorepinephrine levels during continued infusion of norepinephrine (1.0 /u,g/kg) were determined in six dogs. Single doses of propranolol or nicotinic acid were given every 30 or 60 minutes in increasing dose. Plasma free fatty acids were measured at 15 minutes and at one-half hour in 20 animals. The dose response of these agents is shown in Table 1 . The percentage is derived from the expression Observed minus baseline Peak minus baseline X100. These minimally and fully effective doses correspond to the dose responses reported by others (4,10-12).
In low-dose experiments, a concentration was chosen which had a 40% to 60% effect in lowering plasma free fatty acid concentrations toward original levels. The details of the timing and concentrations of various infusions in six groups of experiments are given below.
Group 1: Norepinephrine and low-dose concentrations of propranolol followed by nicotinic acid (4 dogs) a. (15) . The control reagent was highly refined olive oil (Sigma Chemical Company).
Results
The results of these studies appear in Table  2 and Figure 1 . As seen, small doses of propranolol or nicotinic acid in groups 1 and 2, beginning at one hour and ending at 2Jz hours, reduced the concentration of plasma free fatty acids by about 50 percent. However, the combination of the two agents given during the period beginning at 2M hours and ending at 4 hours caused a marked reduction in plasma free fatty acids to a level comparable to the baseline levels and the saline control concentrations. The concentrations of the agents used in groups 1 and 2 were one-fourth to one-tenth the lowest fully effective doses in groups 3 and 4.
It is noted in Table 2 that large doses of the agents in combination (group 4) were no more effective than the combined small doses of the two (groups 1 and 2); nor was a combination of high doses of the agents any more effective than individual high doses of propranolol (group 3).
There was a significant difference between the plasma free fatty acid concentration after 90 minutes of one agent in low dose (ending at 150 minutes into the experiment) and the plasma free fatty acid concentration after the addition of the second agent in a low dose for an additional 90 minutes (ending at 240 minutes into the experiment). The difference in the plasma free fatty acid concentrations was significant at the 5 percent level when the effect of propranolol alone was compared with the effects of the two agents used in combination or if the effect of nicotinic acid alone was compared with the effects of the two agents used in combination. If all the results were pooled, there was again a statistically significant difference between the effect of one agent compared with that of two agents in combination. The effect of the combination of the two agents appeared to be synergistic. Although the concentration of plasma free fatty acids in the animals treated with combinations of low doses of the agents 
Plasma free fatty acid concentrations in the anesthetized dog under the influence of norepinephrine and subsequent addition of low-concentration infusions of propranolol and nicotinic acid in different combinations. The open triangles represent the results of an unopposed infusion of norepinephrine; solid circles, saline controls; open circles, propranolol followed by nicotinic acid; and solid triangles, nicotinic acid followed by propranolol. See text for exact concentrations of low-dose infusions.
appeared to fall below the baseline levels and below the levels in the saline-treated dogs, the differences were not statistically significant.
The results of serum triglyceride determinations are indicated in Table 3 . In the dogs treated with norepinephrine alone (group 5), there was a 13% rise in the serum triglyceride concentration over four hours which was statistically significant at the 5% level. In the dogs treated with norepinephrine for one hour and then with low doses of propranolol and nicotinic acid for three hours (groups 1 and 2), there was a 14% fall in serum triglyceride concentration, which was statistically significant at the 5% level. *Doses of agents are giveri in the Methods section of the text. fStatistically significant differences at the 5 % level compared with the concentration at -15 and 0 minutes.
Suppressive Mffact of Propranolol and Nicolinic Acid on Norepinephrine-induced Release of Free Fally

Discussion
OF PROPRANOI D
Low doses of propranolol and nicotinic acid have a synergistic effect when used in combination. The large doses of propranolol and nicotinic acid used in combination were no more effective than low doses of the two agents used together. This synergistic effect may be explained by the action of these two agents on the same enzyme system involving adenyl cyclase. Both agents have been found to inhibit by different means the activation of adenyl cyclase in the formation of 3'-5' cyclic AMP, necessary for lipolysis in the adipose tissue cell (8, 9) . This type of synergistic effect has been illustrated in the converse process, that is, the activation of adenyl cyclase (16) . In these studies, low doses of adrenocorticotropin (ACTH), epinephrine, and glucagon had a marked effect on the activation of this enzyme system when used in combination at low doses, but there was little effect when the substances were used individually at the same doses.
Nicotinic acid and propranolol have been shown to have their main effects in lowering plasma free fatty acid concentrations via the inhibition of lipolysis at the fat cell level (3, 5-9, 17). As reviewed by Fain (11) , there appear to be three mechanisms of lipolysis in the adipose cell. One mechanism consists of a beta-adrenergic receptor which is solely sensitive to beta catecholamines. Another type of receptor mechanism is involved in lipolysis mediated by ACTH. Finally, the mechanism of lipolysis produced by growth hormone and corticosteroids involves ribonucleic acid (RNA) and protein synthesis and requires a lag period of two hours. Propranolol blocks only lipolysis mediated through the betacatecholamine mechanism. Nicotinic acid blocks all three types of activation of lipase (11, 18) . Nicotinic acid does not directly inhibit the action of lipoprotein lipase (19, 20) .
LOWERING OF PLASMA FREE FATTY ACIDS AS A MECHANISM FOR THE INHIBITION OF HEPATIC LIPOGENESIS
The control of plasma free fatty acids has been suggested as an effective and practical means of reducing the hepatic synthesis of plasma lipids (21) . The concentration of plasma free fatty acids has been found to be one of the main factors controlling lipid synthesis in the hepatic, as well as other, cells (22) (23) (24) . A reduction of plasma free fatty acids has been shown to cause a reduction in the extraction by the liver of plasma free fatty acids from the portal blood and a decreased conversion to triglyceride and cholesterol. The effect on serum triglyceride appears within a matter of hours and on cholesterol somewhat later (3, 5-7). In Table 3 it can be seen that norepinephrine caused an elevation of serum triglyceride concentration. Propranolol and nicotinic acid, which inhibited free fatty acid mobilization, caused a fall in serum triglyceride concentration.
There are several other aspects of lipid synthesis which might be expected to be favorably affected by propranolol and nicotinic acid. For example, there is evidence that plasma free fatty acids stimulate secretion of insulin (25, 26) . There is also evidence that insulin secretion leads to an increased extraction of glucose and plasma free fatty acids from the blood and increased utilization of these substances in the synthesis of triglycerides and cholesterol in the liver and other tissues (27) (28) (29) . Propranolol and nicotinic acid should reverse many of these problems and, in part, this has been demonstrated (30) .
PHARMACOLOGICAL IMPLICATIONS
Both propranolol and nicotinic acid in full doses may have troublesome side effects. Nicotinic acid in the therapeutic dose of 3 to 6 grams per day may cause pruritis, nausea, liver damage, hyperuricemia, and other toxic effects (31, 32) . Propranolol in full doses may have undesirable effects such as congestive failure, asthma, hypotension, and allergic rhinitis (33). So far as is known, these disturbances have generally been unrelated to the effect of these two agents on plasma free fatty acids. Thus, the synergistic effect of these two agents in low doses on reducing plasma free fatty acids may be an effective means of inhibiting lipid synthesis while at the same time avoiding or at least minimizing the untoward side effects.
